FORWARD PHARMA A/S (FWPAY.US) announced a tender offer by offeror to purchase for cash from each registered holder of any and all of the outstanding American Depositary Shares (the ADSs) of the Company, at a purchase price of USD 437.00 per ADS (the Purchase Price), less any applicable withholding taxes, upon the terms and conditions set forth in the Offer to Purchase and the Letter of Transmittal. Participants should obtain the Offer to Purchase dated 14/05/2024 and related Letter of Transmittal for complete terms and conditions of the offer. Participants should consult their tax advisor for complete details in reference to withholding taxes.
The terms of the offer are as follows:
Option (1): Take no action [Default option]
Option (2): Tender Shares – USD 437.00 per ADS NET IN CASH (less any applicable withholding taxes）
No guaranteed delivery procedures are being offered in connection with the Tender Offer.
The deadline to tender shares to the offer will be 17/07/2024@ 16:00 (HONG KONG TIME GMT+8).
In the absence of an election, no action will be taken.
Please fill in the following information and use the registered email address of Futu to send an email to cs@futuhk.com.
1. Account Number:
2. Name: (In Chinese or English)
3. Stock code: FWPAY.US
4. Options: (1) or (2)
5. Number of shares participating in corporate actions:
Note to applicants:
1. For shareholders holding less than 1 share of FWPAY.US, they cannot participate in related corporate actions.
2. Option (1) is the default option. We will help clients to choose option (1) if have not received clients’ emails.
3. Once the relevant application is submitted, the stocks participating in the company's actions cannot be traded and the application cannot be withdrawn.
4. This corporate action does not accept additional applications, the maximum number of applications that a client can apply for does not exceed the number of eligible shares it holds.
5. The pending orders and unsettled shares will not be accepted for the time being.
6. Please confirm that the account funds are sufficient to pay the relevant fees of this corporate action. Otherwise, we will not bear any responsibility for the failure of your application.
7. If there is any update, all the information released by the listed company shall prevail.
